20.05.2013
- AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry...
11.05.2013
- The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer and...
03.05.2013
- Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market. The global...
03.05.2013
- Is nanomedicine the next big thing? A growing number of top drug companies seem to think so. The ability to encapsulate potent drugs in tiny particles measuring billionths of a...
25.04.2013
- AstraZeneca's sales fell by a bigger-than-expected 13% in the first quarter as patent expiries took a heavy toll, underscoring the turnaround challenge facing Britain's second...
22.04.2013
- AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery system...
03.04.2013
- Shares of Optimer Pharmaceuticals rose as much as 24% after a Bloomberg report said GlaxoSmithKline and Cubist Pharmaceuticals were among those interested in buying the antibiotic...
03.04.2013
- AstraZeneca boosted its early-stage pipeline of experimental heart drugs on Wednesday by buying privately held U.S. biotechnology company AlphaCore Pharma, which is developing a...
